| Literature DB >> 33790060 |
Rajkamal Vishnu1, Guruprasad D Rai1, Ganesh Sevagur Kamath1, Vijaya Kumara2.
Abstract
BACKGROUND: Refractory empyemas with collapsed lung and persistent bronchopleural fistulas pose significant problems to thoracic surgeons and impose a substantial burden in terms of morbidity and mortality. The modified Eloesser flap procedure is a useful palliative option for clearing infections. Herein, we present our experiences with the modified Eloesser flap procedure in mixed suppurative lung pathologies with a new technique of irrigation for persistent infection.Entities:
Keywords: Lung disease; Modified Eloesser flap; Povidone-iodine; Therapeutic irrigation; Thoracic empyemas tuberculosis
Year: 2021 PMID: 33790060 PMCID: PMC8038880 DOI: 10.5090/jcs.20.144
Source DB: PubMed Journal: J Chest Surg ISSN: 2765-1606
Preoperative patient status, tuberculosis category, and treatment
| Variable | No. (%) |
|---|---|
| Total no. of patients in the study group | 56 (100.00) |
| Total no. of pulmonary tuberculosis patients | 20 (35.71) |
| Patients on anti-tubercular drugs prior to MEF[ | 20 (35.71) |
| Sputum-positive at the time of MEF | 9 (16.07) |
| Sputum-negative at the time of MEF | 11 (19.64) |
| Total no. of MDR-TB patients | 9 (16.07) |
MEF, modified Eloesser flap; MDR, multi-drug-resistant; TB, tuberculosis; RNTCP, Revised National TB Control Programme.
a)For new cases of pulmonary tuberculosis, the treatment regimen as per RNTCP included 2 months of isoniazid, rifampicin, ethambutol, and pyrazinamide in the intensive phase and 4 months of isoniazid, rifampicin, and ethambutol in the continuation phase. b)The MDR-TB treatment regimen as per RNTCP included 6–9 months of kanamycin, levofloxacin, ethionamide, cycloserine, pyrazinamide, and ethambutol in the intensive phase and 18 months of levofloxacin, ethionamide, cycloserine, and ethambutol in the continuation phase.
Fig. 1Heterogeneity of infections. BPF, bronchopleural fistula.
Fig. 2Types of micro-organisms. Values are presented as % of the number of patients.
Intraoperative and postoperative outcomes of patients undergoing the modified Eloesser flap and our irrigation method
| Outcomes | Value |
|---|---|
| Inverted U-flap | 100 (56) |
| In-hospital mortality | 0 |
| Mean postoperative stay (day) | 8.73 (6–13) |
| Follow-up status | |
| Stoma patent | 50 (28) |
| Stoma closed | 50 (28) |
| Mean stoma closure time (mo) | 7±4.2 |
| Continuous irrigation success rate (first time) | 81 (9) |
| Continuous irrigation success rate (second time) | 100 (2) |
Values are presented as % (number), mean (range), or mean±standard deviation.
Fig. 3(A) Postoperative follow-up after 1 month, showing a well-healed stoma. (B) Postoperative chest X-ray with an expanded lung on the left side.
Fig. 4(A, B) Continuous irrigation method with a pigtail catheter and colostomy bag for collection of drainage.